These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4215671)

  • 1. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry.
    Constantinidis J; Geissbühler F; Gaillard JM; Hovaguimian T; Tissot R
    Experientia; 1974 Oct; 30(10):1182-3. PubMed ID: 4215671
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 5. A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone.
    Horst WD; Spirt N
    Life Sci; 1974 Sep; 15(6):1073-82. PubMed ID: 4157277
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lithium on cerebral monoamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Schou M
    Psychopharmacologia; 1967; 11(4):345-53. PubMed ID: 5590421
    [No Abstract]   [Full Text] [Related]  

  • 8. MK-771 enhances the turnover of norepinephrine in brain.
    Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
    Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
    J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of TRH on the capture and storage of noradrenaline by the isolated ductus deferens of the rat].
    Gudiol T; Rodríguez Farré E; Valdecasas FG
    Arch Farmacol Toxicol; 1978 Apr; 4(1):8-9. PubMed ID: 100063
    [No Abstract]   [Full Text] [Related]  

  • 11. Central catecholamine turnover and self-stimulation behaviour.
    Arbuthnott G; Fuxe K; Ungerstedt U
    Brain Res; 1971 Apr; 27(2):406-13. PubMed ID: 5552182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Releasing hormone on the lateral hypothalamus self-stimulation behavior of rats (author's transl)].
    Kojima H; Inanaga K; Noda Y; Kawaguchi E; Kajiwara U
    No To Shinkei; 1977 Nov; 29(11):1207-13. PubMed ID: 412506
    [No Abstract]   [Full Text] [Related]  

  • 13. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
    Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
    Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
    [No Abstract]   [Full Text] [Related]  

  • 15. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of thyrotropin-releasing hormone on the behaviour of rats pretreated with alpha-methyltyrosine.
    Kulig BM
    Neuropharmacology; 1975 Jul; 14(7):489-92. PubMed ID: 807866
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that serotonin neurons stimulate secretion of prolaction releasing factor.
    Clemens JA; Roush ME; Fuller RW
    Life Sci; 1978 Jun; 22(24):2209-13. PubMed ID: 97485
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
    Katsumata T; Katayama Y; Ootori T; Muramatsu H; Nishiyama Y; Nakamura H; Seta T; Terashi A
    Brain Res; 2001 May; 901(1-2):62-70. PubMed ID: 11368951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecamylamine blockade of nicotine enhanced noradrenaline turnover in rat brain.
    Morgan WW; Pfeil KA
    Life Sci; 1979 Jan; 24(5):417-20. PubMed ID: 431328
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyrotropin releasing hormone (TRH): depressant action on central neuronal activity.
    Renaud LP; Martin JB
    Brain Res; 1975 Mar; 86(1):150-4. PubMed ID: 803854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.